Savara (SVRA) Shares Issued (2012 - 2026)
Savara (SVRA) posted quarterly Shares Issued of $12.9 million for Q1 2026, down 1.63% year-over-year from $13.1 million in Q1 2025, and down 2.79% quarter-over-quarter from $13.2 million in Q4 2025.
Savara (SVRA) Shares Issued (2012 - 2026) Analysis & Trends
Savara (SVRA) has reported Shares Issued for 15 consecutive years, with $12.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 1.63% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 1.63% YoY), while the FY2025 annual figure was $13.2 million, down 2.3% from the prior year.
- Shares Issued eased to $12.9 million in Q1 2026 per SVRA's latest filing, from $13.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $13.6 million in Q4 2024 and bottomed at $5.9 million in Q3 2022.
- Historically, Shares Issued has averaged $10.0 million across 5 years, with a median of $9.6 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Issued surged 196.64% — and 2025, when it retreated 2.3%.
- Savara's Shares Issued stood at $7.9 million in 2022, then climbed by 21.43% to $9.6 million in 2023, then jumped by 40.71% to $13.6 million in 2024, then dropped by 2.3% to $13.2 million in 2025, then declined by 2.79% to $12.9 million in 2026.
- Business Quant data shows SVRA's Shares Issued at $12.9 million in Q1 2026, $13.2 million in Q4 2025, and $13.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - | 12.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.23 Mn |
| Jun 30, 2026 | 12.23 Mn |
| Mar 31, 2026 | 12.87 Mn |
| Mar 31, 2026 | 12.87 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Dec 31, 2025 | 13.24 Mn |
| Sep 30, 2025 | 13.21 Mn |
| Sep 30, 2025 | 13.21 Mn |
| Jun 30, 2025 | 13.19 Mn |
| Jun 30, 2025 | 13.19 Mn |
| Mar 31, 2025 | 13.09 Mn |
| Mar 31, 2025 | 13.09 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Sep 30, 2024 | 9.48 Mn |
| Sep 30, 2024 | 9.48 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 9.79 Mn |
| Mar 31, 2024 | 9.79 Mn |